2026-01-22 - Analysis Report
**Stock Overview**

Estée Lauder is a multinational cosmetics company that offers a range of products for skin care, makeup, hair care, fragrances, and other personal care items.

### Comparison of Return Rates

| Ticker | Cumulative Return |
| --- | --- |
| EL  | -23.82%  |
| VOO | 91.55% |

**Divergence**: The cumulative return of EL is significantly lower than VOO, with a current divergence of -118.90. This is a relative divergence of 8.90%, indicating that the difference between EL and VOO is within the 90th percentile of past data.

### Historical Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 22.0% | 19.7% | 17.0% | 0.8 | 46.9B |
| 2017-2019  | 59.0% | 19.7% | 41.0% | 0.9 | 74.4B |
| 2018-2020  | 10.0% | 21.2% | -11.0% | 0.9 | 95.9B |
| 2019-2021  | 46.0% | 21.2% | 3.0% | 1.0 | 133.4B |
| 2020-2022  | -43.0% | 50.3% | -41.0% | 1.1 | 89.4B |
| 2021-2023  | -68.0% | 58.4% | -69.0% | 1.3 | 52.7B |
| 2022-2024  | -101.0% | 64.6% | -121.0% | 1.3 | 27.0B |
| 2023-2025  | -44.0% | 63.7% | -106.0% | 1.3 | 37.7B |

Note: The historical data shows that EL's CAGR, MDD, Alpha, and Beta have varied significantly across different years. Alpha has been positive in some years, while negative in others. Beta has been relatively high, indicating a high degree of correlation with the market.

### Recent Stock Price Fluctuations

* Close: $117.87
* Last-market: 
  - price: $117.87
  - previousClose: $114.46
  - change: $2.98
* 5-day SMA: $115.99
* 20-day SMA: $110.49
* 60-day SMA: $101.17

Note: The recent stock price fluctuations show that the price has increased by $2.98 from the previous close, with the 5-day SMA and 20-day SMA indicating a bullish trend.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.80 (High Investment Recommended)
* RSI: 72.15
* PPO: 0.26
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium
* Recent (20 days) relative divergence change: 1.00 (+): improving
* 7-day Rank change: 0 (0): flat
* 7-day Dynamic Expected Return change: 0.00 (0): flat
* Expected Return (%): -763.40%

Note: The RSI and PPO indicators suggest that the stock is overbought, according to a general threshold of 70. The MRI indicates a moderately high risk, and the hybrid signal recommends a buy with 0% cash allocation.

### Recent News and Events

* [2026-01-21] Estee Lauder Companies (NYSE:EL) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat (link)
* [2026-01-21] Assessing Estée Lauder (EL) Valuation After Recent Share Price Momentum And Premium P/S Multiple - simplywall.st (link)
* [2026-01-21] Estee Lauder (EL): TD Cowen Raises Price Target to $130 | EL Sto - GuruFocus (link)
* [2025-10-20] EL Stock Price and Chart — NYSE:EL - TradingView — Track All Markets (link)
* [2025-12-02] Why Estée Lauder (EL) Stock Is Trading Up Today - Yahoo Finance (link)
* [2026-01-05] Raymond James Upgrades Estée Lauder Companies (EL) - Nasdaq (link)

Note: The recent news and events suggest that analysts are upbeat about the company's prospects, with TD Cowen raising its price target to $130.

### Analyst Opinions

```
 Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.42 (~Buy)
- Opinions: 24
- Target Price (avg/high/low): 109.58 / 131.00 / 65.00
```

### Recent Earnings Analysis

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-30 | 0.13 | 3.48B$ |
| 2025-05-01 | 0.44 | 3.55B$ |
| 2025-02-04 | -1.64 | 4.00B$ |
| 2024-10-31 | -0.43 | 3.36B$ |

Note: The recent earnings analysis shows that the company's earnings per share (EPS) have fluctuated significantly, with a positive EPS in the latest quarter.

### Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.48B | 73.37% |
| 2025-06-30 | $3.41B | 72.00% |
| 2025-03-31 | $3.55B | 74.96% |
| 2024-12-31 | $4.00B | 76.10% |
| 2024-09-30 | $3.36B | 72.39% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.89B | 1.21% |
| 2025-06-30 | $3.87B | -14.13% |
| 2025-03-31 | $4.34B | 3.66% |
| 2024-12-31 | $4.17B | -14.15% |
| 2024-09-30 | $5.08B | -3.07% |

Note: The financial information shows that the company's revenue and profit margin have fluctuated significantly, with a positive profit margin in some quarters and a negative margin in others. The return on equity (ROE) has also been negative in some quarters.

### Comprehensive Analysis (Summary of previous items)

The recent analysis suggests that the stock has a high degree of correlation with the market, with a high Beta value. The RSI and PPO indicators suggest that the stock is overbought, according to a general threshold of 70. The market risk indicator (MRI) suggests a moderately high risk. Analysts are upbeat about the company's prospects, with TD Cowen raising its price target to $130. The financial information shows that the company's revenue and profit margin have fluctuated significantly, with a positive profit margin in some quarters and a negative margin in others.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.